Basic Information
ID: ALA3539366
Type: ADME
Description: Activity of recombinant human CYP2C9 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated compound formation treated with (R)-episesamin monocatechol at 1 to 30 uM after 15 mins by HPLC analysis in presence of NADPH
Format: BAO_0000219
Organism: Homo sapiens
Cell type: AH22
Target: Cytochrome P450 2C9(ALA3397)
Document: ALA3525932
Activity of recombinant human CYP2C9 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated compound formation treated with (R)-episesamin monocatechol at 1 to 30 uM after 15 mins by HPLC analysis in presence of NADPH: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3539366
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 330.34 | 2.58 | 2.58 |